Lynn Seely

2019

In 2019, Lynn Seely earned a total compensation of $6.2M as Principal Executive Officer at Myovant Sciences Ltd., a 40% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$433,000
Option Awards$5,188,188
Salary$601,000
Other$479
Total$6,222,667

Seely received $5.2M in option awards, accounting for 83% of the total pay in 2019.

Seely also received $433K in non-equity incentive plan, $601K in salary and $479 in other compensation.

Rankings

In 2019, Lynn Seely's compensation ranked 1,615th out of 13,971 executives tracked by ExecPay. In other words, Seely earned more than 88.4% of executives.

ClassificationRankingPercentile
All
1,615
out of 13,971
88th
Division
Manufacturing
579
out of 5,701
90th
Major group
Chemicals And Allied Products
174
out of 2,200
92nd
Industry group
Drugs
140
out of 1,886
93rd
Industry
Pharmaceutical Preparations
105
out of 1,398
93rd
Source: SEC filing on July 24, 2020.

Seely's colleagues

We found two more compensation records of executives who worked with Lynn Seely at Myovant Sciences Ltd. in 2019.

2019

Matthew Lang

Myovant Sciences Ltd.

General Counsel

2019

Frank Karbe

Myovant Sciences Ltd.

Principal Financial and Accounting Officer

News

In-depth

You may also like